daytrading nov 21 morning, page-2

RNO - Stock for the XMAS.

Rhinomed's respiratory device increase airflow through the nose

Thursday, November 21, 2013 by Proactive Investors

Rhinomed has released its inaugural product Turbine™, which increases airflow through the nose.

Medical technology company Rhinomed (ASX: RNO) has released its inaugural product Turbine™, which increases airflow through the nose.

The respiratory sport technology device is purported to increase airflow by up to 38% and has been trialed and used by leading professional cyclists, including Mark O’Brien and Australian Olympian cyclist Rob Crowe.

This targets the billion dollar Australian sport and exercise market, particularly the cycling, triathlon, running and aerobic sport markets.

It will then expand its reach globally through international affiliate sites and distribution channels in 2014.

http://www.proactiveinvestors.com.au/companies/news/50399/rhinomeds-respiratory-device-increase-airflow-through-the-nose-50399.html